Edition:
India

Alcidion Group Ltd (ALC.AX)

ALC.AX on Australia Stock Exchange

0.22AUD
28 Jan 2020
Change (% chg)

-- (--)
Prev Close
$0.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,441,551
52-wk High
$0.31
52-wk Low
$0.04

Summary

Name Age Since Current Position

Rebecca Wilson

2019 Non-Executive Chairman of the Board

Kate Quirke

2019 Chief Executive Officer, Group Managing Director, Director

Colin MacKinnon

2019 Chief Financial Officer, Chief Operating Officer

Melanie Leydin

2019 Joint Company Secretary

Michael Sapountzis

2019 Joint Company Secretary

Nicholas Dignam

2016 Director

Malcolm Pradhan

2016 Director

Simon Chamberlain

2019 Non-Executive Director

Biographies

Name Description

Rebecca Wilson

Ms. Rebecca Wilson is Non-Executive Chairman of the Board of the Company. Ms Wilson is currently CEO of WE Buchan and has dedicated the last 18 years to working within the health and technology sectors providing advice on stakeholder communications, issues management, investor and corporate relations, and business strategy to private and public companies, research institutes, governments, and asset / wealth managers. She has a strong network of investors in Australia, South East Asia and the US and has a deep knowledge and experience of corporate governance having worked, almost exclusively, with ASX companies over the last two decades. She has a BA (Journalism) and Post-Graduate Certificate in Applied Finance and Investment.

Kate Quirke

Ms. Kate Elizabeth Quirke is Chief Executive Officer, Group Managing Director, Director of the company. She is a former CEO of MKM Health, has been appointed to the role of Chief Executive of the Alcidion Group, as well as an Executive Director to the Alcidion Board. Kate is a highly experienced executive with deep expertise in the healthcare IT sector. Ray Blight, previously Alcidion’s Chairman and CEO willmove to the role of Executive Chairman and continue to have an active role in driving the future growth of the combined group.

Colin MacKinnon

Mr. Colin MacKinnon is appointed as Chief Financial Officer, Chief Operating Officer of the Company effective 28 February 2019. He was a co-founder of MKM Health where he had responsibility for the commercial operations and financial management of both MKM Health and Patientrack for the past 16 years. He has over 35 years’ experience in building and managing businesses offering IT solutions and services across Australia, New Zealand and UK including managing the operational integration of acquired businesses. He holds a first class honours degree in business, majoring in IT and finance and is a Chartered Accountant and member of the Australian Institute of Company Directors. Colin is based in Sydney.

Melanie Leydin

Ms. Melanie Jaye Leydin is Joint Company Secretary of the Company. Melanie Leydin has over 13 years’ experience as a Company Secretary. Melanie is also a Chartered Accountant and a Registered Company Auditor. Her experience in public company responsibilities includes ASX and ASIC compliance, control and implementation of corporate governance, statutory financial reporting, reorganisation of companies and shareholder relations.

Michael Sapountzis

Mr. Michael Sapountzis is Joint Company Secretary of the Company. He is a governance professional and Company Secretary. Michael has extensive experience in providing executive support and managing the regulatory requirements for a variety of ASX listed companies. He holds degrees in Law and Commerce and a Graduate Diploma of Applied Corporate Governance.

Nicholas Dignam

Malcolm Pradhan

Simon Chamberlain

Mr. Simon Chamberlain is appointed as Non-Executive Director of the Company., effective 01 July 2019. An accomplished executive and business leader with a skillset that strongly complements Alcidion’s Board, Mr Chamberlain’s 20-year career spans executive roles at high profile companies including General Manager at Medibank Private, Executive Manager of Qantas Airways’ Hooroo business, and most recently in his current role as General Manager at MedAdvisor (ASX: MDR). Mr Chamberlain has enjoyed a rich and varied career, with a proven track record for strategic success and commercial growth across a range of industries and markets. Simon led Qantas’ entrance into the online hotels business, establishing a profitable, high growth new division for Qantas. At Medibank, Simon had responsibility across all customer channels and the enterprise’s data and oversaw the creation of the customer experience practice. Gaining a better understanding of the complex challenges facing the wider health system led to Simon’s role leading strategy for MedAdvisor, where he has helped support the global expansion of their health technology business. Simon brings a valuable international perspective and global network to the Alcidion Board, holding executive roles across the US and the UK where he was a key part of the executive team that sold the Australian start-up, Hitwise, to Experian in 2007. Simon holds a Bachelor of Commerce (Accounting) and Law (Hons) from Monash University.